KDEV — Karolinska Development AB Share Price
0.000.00%
Last trade - 00:00- SEK419.32m
- SEK326.73m
- SEK2.01m
- 44
- 26
- 54
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.34 | ||
| Price to Tang. Book | 0.34 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 208.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.28% | ||
| Return on Equity | 0.43% | ||
| Operating Margin | -174.03% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 3.38 | 2.65 | 2.17 | 2.3 | 2.01 | 2 | 2 | -8.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +762.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.
Directors
- Bjorn Cochlovius NEC (53)
- Viktor Drvota CEO (56)
- Johan Dighed DCE (48)
- Tse Ping VCH (69)
- Per Aniansson CFO (55)
- Elisabet Gimbringer FID (56)
- Eva Montgomerie CAO (63)
- John Ohd CSO (50)
- Ben Toogood DRC (45)
- Theresa Tse DRC (29)
- Anna Skjoldebrand IND (52)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 7th, 2006
- Public Since
- April 15th, 2011
- No. of Employees
- 8
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 269,833,309
- Address
- Tomtebodavagen 23 A, SOLNA, 171 65
- Web
- https://www.karolinskadevelopment.com/
- Phone
- +46 852486070
- Auditors
- Ernst & Young AB
Upcoming Events for KDEV
Karolinska Development AB Annual Shareholders Meeting
Karolinska Development AB Annual Shareholders Meeting
Q2 2024 Karolinska Development AB Earnings Release
Similar to KDEV
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Karolinska Development AB share price?
As of Today at 19:12 UTC, shares in Karolinska Development AB are trading at SEK1.55. This share price information is delayed by 15 minutes.
How has the Karolinska Development AB share price performed this year?
Shares in Karolinska Development AB last closed at SEK1.55 and the price had moved by -8.48% over the past 365 days. In terms of relative price strength the Karolinska Development AB share price has underperformed the FTSE Global All Cap Index by -15.58% over the past year.
What are the analyst and broker recommendations for Karolinska Development AB?
The overall consensus recommendation for Karolinska Development AB is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Karolinska Development AB dividend yield?
Karolinska Development AB does not currently pay a dividend.
Does Karolinska Development AB pay a dividend?
Karolinska Development AB does not currently pay a dividend.
When does Karolinska Development AB next pay dividends?
Karolinska Development AB does not currently pay a dividend.
How do I buy Karolinska Development AB shares?
To buy shares in Karolinska Development AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Karolinska Development AB?
As of the previous close price of SEK1.55, shares in Karolinska Development AB had a market capitalisation of SEK419.32m.
Where are Karolinska Development AB shares listed?
Here are the trading details for Karolinska Development AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: KDEV
What kind of share is Karolinska Development AB?
Based on an overall assessment of its quality, value and momentum Karolinska Development AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Karolinska Development AB share price forecast for 2024?
The analyst consensus target price for shares in Karolinska Development AB is SEK4.50. That is 189.58% above the last closing price of SEK1.55.
Analysts covering Karolinska Development AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.06 for the next financial year.
What is the trend in the Karolinska Development AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Karolinska Development AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -11.47%.
As of the last closing price of SEK1.55, shares in Karolinska Development AB were trading -4.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Karolinska Development AB PE Ratio?
The Karolinska Development AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK1.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Karolinska Development AB?
Karolinska Development AB's management team is headed by:
- Bjorn Cochlovius - NEC
- Viktor Drvota - CEO
- Johan Dighed - DCE
- Tse Ping - VCH
- Per Aniansson - CFO
- Elisabet Gimbringer - FID
- Eva Montgomerie - CAO
- John Ohd - CSO
- Ben Toogood - DRC
- Theresa Tse - DRC
- Anna Skjoldebrand - IND